Robust Score Can ID Infection Risk in Newly Diagnosed Multiple Myeloma

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 19, 2023.

By Elana Gotkine HealthDay Reporter

TUESDAY, Dec. 19, 2023 -- A robust score can identify patients with newly diagnosed multiple myeloma (NDMM) at risk for severe infection/death, according to a study published online Dec. 7 in Leukemia.

Elias K. Mai, M.D., from the University Hospital Heidelberg in Germany, and colleagues examined 3,700 transplant-eligible NDMM patients treated in 2005 to 2020 with novel agent-based triplet/quadruplet induction therapy (IT). The patients were categorized into a training cohort (1,333 patients) and three validation cohorts (2,367 patients).

The researchers found that 11.8, 1.8, and 12.5 percent of patients in the training cohort experienced severe infections, death, or both, respectively, during IT. Low platelet count (<150 n/L), International Staging System III, higher World Health Organization performance status (>1), and age (older than 60 years) were identified as major baseline risk factors for severe infection/death. In the low- versus intermediate- versus high-risk groups, the risk for severe infection increased from 7.7 to 11.5 to 23.3 percent, respectively. In three trials incorporating quadruplet IT with an anti-CD38 antibody, the risk score was independently validated.

"Our study highlights the importance of early severe infections and death in the era of novel agent-based therapy in patients with NDMM," the authors write. "Based on our risk score, patients at high risk of early, severe infections and death can be easily identified upfront, when evaluated for the latest quadruplet induction therapies including an anti-CD38 monoclonal antibody."

Several authors disclosed ties to the biopharmaceutical industry, including several companies that funded the trials.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-20 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords